29 M	N-[2-{[benzyl(methyl)amino]methyl}-3-(4-fluoro-2-methoxyphenyl)-5-(propan-2-yl)-1H-indol-7-yl]
	methanesulfonamide
AD4	AutoDock 4.2
ADR	adverse drug reaction
AR	androgen receptor
CMM	2-[2-(1-carbamimidoyl-piperidin-3-YL)-acetylamino]-3-{4-[2-(3-oxalyl-1H-indol-7-YL)ethyl]-phenyl}-
	propionic acid methyl ester
EM5744	(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-Difluorobenzyl)oxy]ethyl}-17-hydroxy-10-
	methylhexadecahydro-3H-cyclopenta[A]phenanthren-3-one
FDA	United States Food and Drug Administration
FRG	(R)-N-[2-[1-(Aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methyl ester
GCR	glucocorticoid receptor
GLIDE	Schrödinger’s Glide 2016-4
GWI	Gulf War Illness
HPA	hypothalamic–pituitary–adrenal
HPG	hypothalamic–pituitary–gonadal
IL	interleukin
M21	ala-cys-pro-pro-cys-leu-trp-gln-val-leu-cys-gly
MADM	median absolute deviation from the median
NPV	negative predictive value
PDB	Protein Data Bank
PPV	positive predictive value
RMSD	root mean square deviation
TNF	tumor necrosis factor
VINA	AutoDock Vina 1.1.2